Skip to main content
Premium Trial:

Request an Annual Quote

Helicos Again Cuts IPO Share Price, Down 40 Percent From High End of Original Price Range

NEW YORK (GenomeWeb News) — Helicos for the second time in a week ratcheted down its share price for its planned initial public offering, cutting the price of its shares to $9 — a 40-percent drop from the high end of its original plan — according to a filing with the US Securities and Exchange Commission today.
Earlier this week, the company cut the price of the 5.4 million shares it is offering to between $10 and $11 per share from an original projection of between $13 and $15 per share, according to an earlier SEC filing.
Helicos now expects to raise about $43.2 million in net proceeds from the IPO, and as much as $50 million if underwriters fully exercise an over-allotment option.
The firm's adjusted capitalization also was cut to $66.7 million to reflect the lower proceeds.
Helicos said it plans to use about $20 million of the proceeds to develop its HeliScope system and its tSMS technology.
The remaining $20 million or so will pay for sales, marketing, and manufacturing efforts for the HeliScope.
In a prospectus filed on May 7, Helicos initially estimated it would price its shares in the $13 to $15 range, but on May 23 the company reduced that range to between $10 and $11 per share.
As GenomeWeb Daily News reported at the time, if the Helicos IPO is successful the firm will become the only publicly traded pure-play next-generation sequencing company.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.